Generic semaglutide is now cheap in India. Here is what it does to your muscle
The short answer
Generic semaglutide went on sale in India on 21 March 2026, the day after the patent expired, at a fraction of the old price. It works: in the main trial people lost about 15 percent of their body weight. But a large 2026 review found that a median of about 28 percent of the weight lost on these drugs came from muscle-related tissue, and when people in the trial stopped, they regained two-thirds of the loss within a year. Strength training and enough protein are the best tools we have for keeping muscle while the weight comes off, and the first trials testing them alongside these drugs are still running. Whether to take the drug is your doctor's decision. Keeping your muscle while you do is ours.
Written by Brijesh Joshi
Founder of S R Gym, Surat, coaching since 1999. President of the Strength Bodybuilding Association South Gujarat and a registered IBBFF judge. See credentials.
- Published
- Last reviewed
- Reviewed
- Reading time
- 8 min read
What changed in March
Semaglutide, the drug sold as Ozempic and Wegovy, lost its core patent protection in India on 20 March 2026. The next day a long list of Indian manufacturers launched their own versions, among them Sun Pharma, Dr Reddy's, Glenmark, Zydus and Alkem. Dr Reddy's priced its pen at about ₹4,200 a month. A drug that had been out of reach for most families is now within it.
I am a gym coach, not a doctor, and nothing on this page is advice about whether to take it, what dose, or for how long. That belongs to your doctor. But people on these drugs are already walking into gyms, and the part of the story that matters most to them is the part that happens below the skin.
It works, and that is not in dispute
In the main trial, published in the New England Journal of Medicine in 2021, adults with obesity who took semaglutide weekly for 68 weeks lost an average of 14.9 percent of their body weight, against 2.4 percent on placebo. For someone at 95 kg, that is around 14 kg. Very few diets achieve that, and fewer still hold it.
How much of the weight is muscle
Every kind of weight loss takes some lean tissue with the fat. The question is how much. A systematic review published in the Annals of Internal Medicine this year pulled together 35 trials of these drugs. The median share of weight lost from muscle-related measures was about 28 percent, and in roughly two-thirds of the studies it was higher than the authors expected for ordinary weight loss.
I want to be careful with that number. It varied widely between studies, some measured lean mass rather than muscle itself, and not one of them measured whether people became weaker or less able to climb stairs. So nobody can yet say the drug makes you frail. What can be said is that if a quarter or more of what you lose is muscle, you are losing the tissue that keeps your metabolism up, your joints supported and your blood sugar in check as you age. That is worth protecting on purpose.
What happens when you stop
The trial followed some participants for a year after the injections ended. They regained about two-thirds of the weight they had lost, and most of the improvements in blood pressure and blood sugar drifted back too. That is not a failure of willpower. The drug changes appetite while you take it, and when it stops, appetite comes back.
A separate Danish trial, with liraglutide, an older drug in the same family, is the most useful one I have found for this. A year after treatment ended, people who had combined the drug with supervised exercise weighed about 5 kg less than those who had taken the drug alone. Exercise was the part that kept working after the prescription stopped. This is the same pattern as weight regain after any diet.
What training can do about it
The case for strength training during weight loss is older than these drugs. A review of 52 studies in adults over fifty found that 81 percent of diet-only groups lost at least 15 percent of their weight as lean tissue, against 39 percent of groups that also exercised. Muscle that is being used is muscle the body holds on to.
Trials testing strength training and protein directly alongside semaglutide are only now running. One published this year is randomising 232 adults to resistance exercise, high protein, both, or neither, and its results are not out. So I will not tell you the combination is proven. I will tell you it is what I would do: two or three full-body sessions a week built around squats, presses, rows and hinges, with load that rises gradually, which is what strength training here already is.
One practical note. People on these drugs often eat so little that a normal session leaves them light-headed. Tell your coach you are on it, eat something before you train, and stop if you feel faint. If you are also on medication for diabetes, your doctor needs to know you are training, because low blood sugar is a real risk.
Protein, on a Gujarati plate
India's national requirement for healthy adults is 0.83 g of protein per kg of body weight a day. On a vegetarian Gujarati diet, plenty of people fall short of that before they start a drug that sharply reduces their appetite. When you can only manage small meals, what is on the plate matters more: dal, curd, paneer, chana and soya first, rotli and rice after. Protein for Indian vegetarians works through the numbers, and the protein calculator gives you your own figure. If you have kidney disease, ask your doctor before raising protein at all.
What a coach should not do
A trainer should not tell you to start, stop or change the dose of a prescription drug, sell you one, or source one for you. If a gym offers you semaglutide, leave. What a coach can do is make sure the weight you lose is fat rather than muscle, and that you have habits in place for the day the prescription ends. That is the job, and it is the same job it was before the drug existed. Fat loss coaching is set up for exactly that.
Questions people are asking
- Is generic semaglutide available in India?
- Yes. The core Indian patent expired on 20 March 2026 and several Indian manufacturers, including Sun Pharma, Dr Reddy's, Glenmark, Zydus and Alkem, launched generic versions from 21 March. It is a prescription medicine and should only be started, dosed and stopped under a doctor's supervision.
- Does semaglutide cause muscle loss?
- Weight loss of any kind takes some lean tissue with the fat. A 2026 systematic review in the Annals of Internal Medicine found that across 35 trials of these drugs, a median of about 28 percent of the weight lost came from muscle-related measures, and in roughly two-thirds of studies the share was above what would normally be expected. The amount varied widely between studies, and none measured physical function, so the practical consequences are not yet clear.
- Should I lift weights while taking semaglutide?
- Resistance training is the best-supported way to protect muscle during any weight loss, and there is no reason to think these drugs change that. Trials testing strength training and protein specifically alongside semaglutide and tirzepatide are underway but have not reported. Tell your doctor you are training, and tell your coach you are on the drug, because appetite, energy and blood sugar can all change.
- What happens if I stop taking semaglutide?
- In the extension of the main trial, people who stopped regained about two-thirds of the weight they had lost within a year, and most of the health improvements went back towards where they started. In a separate trial with liraglutide, people who had also done supervised exercise kept off more weight after stopping than people who had taken the drug alone.
- How much protein do I need while losing weight on semaglutide?
- That is a question for your doctor or a dietitian, particularly if you have kidney disease. As a reference, India's national requirement for healthy adults is 0.83 g per kg of body weight per day, and many people on these drugs struggle to reach even that because their appetite is so reduced. The protein calculator on this site works through it for a vegetarian Gujarati diet.
The research this page rests on
Every figure on this page comes from one of these, checked against the published abstract. The main semaglutide trial was funded by the manufacturer.
-
Once-weekly semaglutide in adults with overweight or obesity (STEP 1)
New England Journal of Medicine, Wilding JPH and colleagues, 2021 · Randomised controlled trial, 1,961 adults without diabetes, 68 weeks
Body weight fell 14.9 percent with semaglutide 2.4 mg against 2.4 percent with placebo, alongside lifestyle advice. Funded by the manufacturer.
-
Diabetes, Obesity and Metabolism, Wilding JPH and colleagues, 2022 · Off-treatment follow-up, 327 participants, one year
After stopping, people regained 11.6 of the 17.3 percentage points they had lost, about two-thirds, and most cardiometabolic improvements reverted towards baseline. The analyses were exploratory.
-
Effect of incretin-based and nonpharmacologic weight loss on body composition: a systematic review
Annals of Internal Medicine, 2026 · Systematic review of 35 randomised trials
A median of 28.3 percent of total weight lost came from muscle-related measures, with 65 percent of studies above the roughly 25 percent benchmark the authors expected. Results varied widely, fewer than half the studies were at low risk of bias, and none measured physical function.
-
Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies
Diabetes, Obesity and Metabolism, Neeland IJ and colleagues, 2024 · Review
Reported lean mass losses ranged from about 15 percent to between 40 and 60 percent of total weight lost depending on the study, and lean mass is not the same measure as muscle.
-
eClinicalMedicine, Lundgren JR and colleagues, 2024 · Post-treatment follow-up of a randomised trial, 109 participants
A year after treatment ended, people who had combined supervised exercise with liraglutide weighed 5.1 kg less than those who had taken liraglutide alone, and regain was 6 kg larger after stopping the drug than after stopping exercise. The drug was liraglutide, an older relative of semaglutide.
-
Nutrition Reviews, Weinheimer EM and colleagues, 2010 · Systematic review of 52 studies, adults 50 and over
81 percent of diet-only groups lost 15 percent or more of their weight as fat-free mass, against 39 percent of groups that added exercise. Mostly aerobic exercise, and not a drug study.
-
BMJ Open, 2026 · Published trial protocol, 232 adults, results not yet available
Tests resistance exercise, protein at 1.6 g/kg/day, or both, alongside semaglutide or tirzepatide. Listed to show that the direct evidence is still being gathered.
-
Pearce IP, 2026 · Legal news report
Generic semaglutide launched on 21 March 2026 after the Indian patent expired on 20 March. Dr Reddy's priced its version at about Rs 4,200 a month.
On semaglutide and want to keep your muscle?
Tell us what your doctor has prescribed and how you are eating, and the training gets built around it.